Showing results (101-110 of 397) with videos related to
Sort By:
Pageof 40
Neurosurgery|August 15, 2018
Is Visible Aminolevulinic Acid-Induced Fluorescence an Independent Biomarker for Prognosis in Histologically Confirmed (World Health Organization 2016) Low-Grade Gliomas?Mohammed Jaber, Christian Ewelt, Johannes Wölfer, et al.Orthopaedics & Traumatology, Surgery & Research : OTSR|October 25, 2018
Outcomes of distal humerus fractures: What are we measuring?Ali Zarezadeh, Kelly Mamelson, W Christian Thomas, et al.World Journal of Urology|June 25, 2024
Treatment trends for undescended testis and impact of guideline changes a medical health care analysis of orchidopexy and cryptorchidism in Germany between 2006 und 2020Marcus Sondermann, Viktoria Menzel, Angelika Borkowetz, et al.Journal of Robotic Surgery|January 6, 2025
The use of laser-assisted cart positioning significantly reduces the docking time of multimodular robotic systemsMartin Baunacke, Christopher Hirtsiefer, Roman Herout, et al.The Journal of International Advanced Otology|November 22, 2024
Magnetic Resonance Imaging in Prediction of Sensorineural Hearing Loss in Patients with NeuroinfectionsFrej Juul Vilhelmsen, Elisa Skovgaard Jensen, Bodil Damgaard, et al.Aktuelle Urologie|May 9, 2019
[Online support groups for patients with prostate cancer]Johannes Huber, Christian Thomas, Philipp Karschuck, et al.Der Urologe. Ausg. A|January 22, 2021
[Health care reality of urological endoprosthetics in Germany from 2006 to 2016]Martin Baunacke, Christer Groeben, Angelika Borkowetz, et al.Urology|March 6, 2012
Functional analysis of elective nephron-sparing surgery vs radical nephrectomy for renal tumors larger than 4 cmFrederik C Roos, Walburgis Brenner, Christian Thomas, et al.World Journal of Urology|June 1, 2023
Insufficient utilization of care in male incontinence surgery: health care reality in Germany from 2006 to 2020 and a systematic review of the international literatureMartin Baunacke, Elena Abbate, Nicole Eisenmenger, et al.Cancers|January 11, 2022
Systemic Triple Therapy in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): Ready for Prime Time or Still to Be Explored?Christian Thomas, Martin Baunacke, Holger H H Erb, et al.Pageof 40